⌕
Merit Medical Systems · MMSI · Nasdaq
Tenet 58 · Mixed
Compare
$84.49−2.15%At closeTenet 58 · Mixed
$84.49−1.86 (−2.15%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

Merit Medical Systems (MMSI) Income Statement

Is this a real, growing, cash-generative business, or a story propped up by accounting?

Sources Company filings FilingsHow we compute thisNot investment advice
Business engineSteady: revenue compounds ~9.0%/yr (FY21→FY25), net margin 8.5%, and free cash flow (~$215.7M) tracks net income. Earnings are cash, not paper. Worth your attention in FY25: Share count (+5.4%) and Capex step-up ($81.7M). Both visible in the receipts below.
The four lines that matter · FY21–FY25
Revenue ($M)▲11.8%
1,515.9
FY21→FY25CAGR +9.0%/yr
Net income ($M)▲6.8%
128.5
one-off year: see footnoteCAGR +27.6%/yr
Free cash flow ($M)▲16.2%
215.7
capex stepped upCAGR +16.0%/yr
Diluted EPS▲4.9%
2.13
FY21→FY25CAGR +26.2%/yr
What the receipts whisper · what a headline number hides
Share count
+5.4%

57.4mn → 60.5mn diluted shares since FY21. Rising share count dilutes EPS. Growth must outrun it.

Capex step-up
$81.7M

▲133% YoY in FY25, largest jump in this window; watch free-cash-flow conversion.

What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)1515.9Revenue−777.6COGS738.3Gross profit−97.4R&D−455.2SG&A184.7Op income−56.2Tax & other128.5Net income

8¢ of every revenue dollar becomes profit. The biggest cost lever is COGS.

Margin trend · direction beats level Gross Operating Net
503825130%sector median net margin ~3%FY21FY25

Over this window: gross 45.2% → 48.7%. Net margin 8.5% is more than double the sector median.

The receipt · income statement · FY21–FY25 USD millions except per-share & ratios · hover a line for its definition
USD millions except per-share & ratios
Line itemTTM †FY25FY24FY23FY22FY21YoYCAGR 21→25
Revenue & profitability
Revenue
1,610.91,515.91,356.51,257.41,151.01,074.8▲11.8%+9.0%
Cost of revenue
815.0777.6713.2673.5631.9589.4▲9.0%+7.2%
Gross profit
795.9738.3643.3583.9519.1485.3▲14.8%+11.1%
Research & development
96.997.487.584.382.271.2▲11.3%+8.1%
Selling, general & admin
481.8455.2399.7373.7342.5335.7▲13.9%+7.9%
Total operating expenses
578.4553.5487.6459.9431.5424.4▲13.5%+6.9%
Operating incomefeeds ROC rank
217.5184.7155.7123.987.660.9▲18.6%+32.0%
Other income, net
−5.8−13.8−5.7−11.9−4.9−7.0——
Pretax income
211.7170.9150.0112.182.653.9▲14.0%+33.4%
Income tax
51.642.429.617.78.15.5▲43.2%+67.0%
Net incomePiotroski ROA ✓feeds Buffett Quality owner earnings
160.1128.5120.494.474.548.5▲6.8%+27.6%
Per share
Diluted EPSbuyback-sensitive
2.672.132.031.621.290.84▲4.9%+26.2%
Diluted shares (mn)
60.3860.4659.3758.3657.6757.36▲1.8%+1.3%
Margins
Gross margin28th pct in Healthcare
49.4%48.7%47.4%46.4%45.1%45.2%▲1.3pp+3.5pp
Operating margin
13.5%12.2%11.5%9.9%7.6%5.7%▲0.7pp+6.5pp
Net margin67th pct in Healthcare
9.9%8.5%8.9%7.5%6.5%4.5%▼0.4pp+4.0pp
† TTM = trailing four quarters through 2026-09-30.FY25 effective tax rate was 25% vs a 16% norm for this window, likely a one-time item; see the filing.
FY09 – FY20 · 12 more years
Unlock the full history →
5 more years of statements and CSV export are on Premium, and 12 more on Ultimate.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
Annual report filed 2026-02-24 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.

What was Merit Medical Systems' revenue last fiscal year?

Merit Medical Systems reported revenue of $1,515.9M in fiscal 2025, up 11.8% from fiscal 2024.

What was Merit Medical Systems' net income?

Merit Medical Systems reported net income of $128.5M in fiscal 2025, a net margin of 8.5%.

Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.